| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Meredith C Meacham, Alicia L Nobles, D Andrew Tompkins, Johannes Thru. "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PloS one. vol 17. issue 2. 2022-02-08. PMID:35134074. |
future research is warranted with more structured assessments that examines the role of cannabis and cannabinoids in addressing both somatic and affective symptoms of opioid withdrawal. |
2022-02-08 |
2023-08-13 |
Not clear |
| Recardia Schoeman, Amy de la Harpe, Natasha Beukes, Carminita L Fros. Cannabis with breast cancer treatment: propitious or pernicious? 3 Biotech. vol 12. issue 2. 2022-02-07. PMID:35127309. |
cannabis is often used for its palliative effects in the form of purified cannabinoids, or as extracts. |
2022-02-07 |
2023-08-13 |
Not clear |
| Shiori Takashina, Miki Takahashi, Koji Morimoto, Koichi Inou. LC-MS/MS Assay for the Measurement of Cannabidiol Profiling in CBD Oil from Japanese Market and Application for Convertible Tetrahydrocannabinol in Acetic Acid Condition. Chemical & pharmaceutical bulletin. vol 70. issue 2. 2022-02-03. PMID:35110438. |
cannabidiol (cbd), a major non-psychoactive cannabinoid, has a lot of attention due to its potential relaxing properties and led the trend in commercial cbd aroma/oral hemp seed oil from the japanese market. |
2022-02-03 |
2023-08-13 |
Not clear |
| Shuangtao Li, Yuanbing Huang, Lijun Yu, Xiaoyu Ji, Jie W. Impact of the cannabinoid system in Alzheimer's diseases. Current neuropharmacology. 2022-02-02. PMID:35105293. |
cannabinoids are compounds that were initially isolated from cannabis marihuana and are also widely present in both nervous and immune systems of animals. |
2022-02-02 |
2023-08-13 |
human |
| Angela L Liang, Erin L Gingher, Jenell S Colema. Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review. Obstetrics and gynecology. vol 139. issue 2. 2022-02-01. PMID:35104069. |
cannabis contains delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd), which are cannabinoids that bind to endocannabinoid system receptors. |
2022-02-01 |
2023-08-13 |
Not clear |
| Christopher A Legare, Wesley M Raup-Konsavage, Kent E Vran. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Pharmacology. 2022-01-30. PMID:35093949. |
while there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited objective data supporting the use of crude materials (cbd oil, cannabis extracts, and/or cannabis itself). |
2022-01-30 |
2023-08-13 |
Not clear |
| Valeria Lallai, Letizia Manca, Yasmine Sherafat, Christie D Fowle. Effects of Prenatal Nicotine, THC or Co-Exposure on Cognitive Behaviors in Adolescent Male and Female Rats. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2022-01-28. PMID:35090174. |
further, given the recent escalation in e-cigarette use and legalization of cannabis, it has become essential to understand the effects of nicotine and cannabinoid co-exposure during early developmental stages. |
2022-01-28 |
2023-08-13 |
rat |
| Lidya Kebede, Seyedehsara Masoomi Dezfooli, Ali Seyfoddi. Medicinal Cannabis Pharmacokinetics and Potential Methods of Delivery. Pharmaceutical development and technology. 2022-01-27. PMID:35084279. |
current cannabis products fail to address the undesirable characteristics associated with cannabinoids such as low solubility, poor bioavailability, and lack of specificity, all of which contribute to low therapeutic effect. |
2022-01-27 |
2023-08-13 |
Not clear |
| Stephanie E Reitsma, Hari Hara Sudhan Lakshmanan, Jennifer Johnson, Jiaqing Pang, Ivan Parra-Izquierdo, Alex R Melrose, Jaewoo Choi, Deirdre E J Anderson, Monica T Hinds, Jan Frederik Stevens, Joseph E Aslan, Owen J T McCarty, Jamie O L. Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in non-human primates reduces systemic platelet activity and function. American journal of physiology. Cell physiology. 2022-01-26. PMID:35080922. |
medical cannabis is administered for treatment of chronic pain based on the premise that the endocannabinoid system signals desensitize pain sensor neurons and produce anti-inflammatory effects. |
2022-01-26 |
2023-08-13 |
Not clear |
| Stephanie E Reitsma, Hari Hara Sudhan Lakshmanan, Jennifer Johnson, Jiaqing Pang, Ivan Parra-Izquierdo, Alex R Melrose, Jaewoo Choi, Deirdre E J Anderson, Monica T Hinds, Jan Frederik Stevens, Joseph E Aslan, Owen J T McCarty, Jamie O L. Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in non-human primates reduces systemic platelet activity and function. American journal of physiology. Cell physiology. 2022-01-26. PMID:35080922. |
the major psychoactive ingredient of cannabis is Δ9-tetrahydrocannabinol (thc) that signals mainly through cannabinoid receptor-1 (cbr), which is also present on non-neuron cells including blood platelets of the circulatory system. |
2022-01-26 |
2023-08-13 |
Not clear |
| Yuki Sugaya, Masanobu Kan. Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures. Frontiers in neural circuits. vol 15. 2022-01-20. PMID:35046779. |
furthermore, recent endocannabinoid research has paved the way for the clinical use of cannabidiol for the treatment of refractory epilepsy, such as dravet syndrome, lennox-gastaut syndrome and tuberous sclerosis complex. |
2022-01-20 |
2023-08-13 |
Not clear |
| Sawitri Assanangkornchai, Kanittha Thaikla, Muhammadfahmee Talek, Darika Sainga. Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey. PeerJ. vol 10. 2022-01-20. PMID:35047242. |
many countries now allow the consumption of cannabis or cannabinoids for medical purposes with varying approaches concerning products allowed and the regulatory frameworks prevailing their endowment. |
2022-01-20 |
2023-08-13 |
Not clear |
| George Sam Wang, Christine Buttorff, Asa Wilks, Daniel Schwam, Gregory J Tung, Shireen Banerji, Richard C Dart, Rosalie Liccardo Pacul. Comparison of hospital claims and poison center data to evaluate health impact of opioids, cannabis and synthetic cannabinoids. The American journal of emergency medicine. vol 53. 2022-01-20. PMID:35051702. |
comparison of hospital claims and poison center data to evaluate health impact of opioids, cannabis and synthetic cannabinoids. |
2022-01-20 |
2023-08-13 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015. BMC pediatrics. vol 22. issue 1. 2022-01-19. PMID:35042455. |
geotemporospatial and causal inference epidemiological analysis of us survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015. |
2022-01-19 |
2023-08-13 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015. BMC pediatrics. vol 22. issue 1. 2022-01-19. PMID:35042455. |
cannabinoids including cannabidiol have recognized genotoxic activities but their significance has not been studied broadly epidemiologically across the teratological spectrum. |
2022-01-19 |
2023-08-13 |
Not clear |
| Maximilian Gahr, Julia Ziller, Ferdinand Keller, Rainer Muche, Ulrich W Preuss, Carlos Schönfeldt-Lecuon. Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation. European journal of public health. 2022-01-19. PMID:35043164. |
increasing availability and use of synthetic cannabinoids and cannabis preparations with increased tetrahydrocannabinol content) changes in cannabinoid use may be associated with changes in the prevalence of cannabinoid-related mental and behavioural disorders and, accordingly, changes in the need for medical care. |
2022-01-19 |
2023-08-13 |
Not clear |
| Bryan W Jenkins, Shoshana Buckhalter, Melissa L Perreault, Jibran Y Khokha. Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents. Schizophrenia bulletin open. vol 3. issue 1. 2022-01-17. PMID:35036917. |
in conclusion, cannabis vapor exposure has varying impacts on oscillatory activity in nvhl rats, and the relative composition of naturally occurring cannabinoids may contribute to this variability. |
2022-01-17 |
2023-08-13 |
rat |
| b' Libor Uttl, Tom\\xc3\\xa1\\xc5\\xa1 Hlo\\xc5\\xbeek, Pavel Mare\\xc5\\xa1, Tom\\xc3\\xa1\\xc5\\xa1 P\\xc3\\xa1len\\xc3\\xad\\xc4\\x8dek, Hana Kubov\\xc3\\xa. Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats. International journal of molecular sciences. vol 23. issue 1. 2022-01-11. PMID:35008517.' |
in spite of use of cannabidiol (cbd), a non-psychoactive cannabinoid, in pediatric patients with epilepsy, preclinical studies on its effects in immature animals are very limited. |
2022-01-11 |
2023-08-13 |
rat |
| Chun S Zuo, Katherine A Davis, Madeline K Kuppe, M Kathryn Dahlgren, Staci Gruber, Garrett M Fitzmaurice, Scott E Luka. Elevated striatal glutamate + glutamine in recreational cannabis users during abstinence. Journal of psychiatric research. vol 146. 2022-01-09. PMID:34999370. |
we hypothesize that cannabis withdrawal may be associated with a reset of regional γ-amino butyric acid (gaba) and glutamate concentrations secondary to changes in the endocannabinoid system during abstinence and conducted a study on this issue. |
2022-01-09 |
2023-08-13 |
human |
| Jodi M Gilman, William A Schmitt, Kevin Potter, Brian Kendzior, Gladys N Pachas, Sarah Hickey, Meena Makary, Marilyn A Huestis, A Eden Evin. Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022-01-09. PMID:34999737. |
the primary cannabinoid in cannabis, Δ9-tetrahydrocannabinol (thc), causes intoxication and impaired function, with implications for traffic, workplace, and other situational safety risks. |
2022-01-09 |
2023-08-13 |
human |